24 related articles for article (PubMed ID: 1800889)
1. The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence.
Fry BN; Feng S; Chen YY; Newell DG; Coloe PJ; Korolik V
Infect Immun; 2000 May; 68(5):2594-601. PubMed ID: 10768949
[TBL] [Abstract][Full Text] [Related]
2. Endotoxemia: methods of detection and clinical correlates.
Hurley JC
Clin Microbiol Rev; 1995 Apr; 8(2):268-92. PubMed ID: 7621402
[TBL] [Abstract][Full Text] [Related]
3. Neisseria gonorrhoeae LPS variation, serum resistance and its induction by cytidine 5'-monophospho-N-acetylneuraminic acid.
Demarco de Hormaeche R; van Crevel R; Hormaeche CE
Microb Pathog; 1991 Apr; 10(4):323-32. PubMed ID: 1716719
[TBL] [Abstract][Full Text] [Related]
4. Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic.
Chamberlain LM; Strugnell R; Dougan G; Hormaeche CE; Demarco de Hormaeche R
Microb Pathog; 1993 Jul; 15(1):51-63. PubMed ID: 8412627
[TBL] [Abstract][Full Text] [Related]
5. Virulence and immunogenicity of types 1 and 3 Neisseria gonorrhoeae in guinea pig subcutaneous chambers.
Arko RJ; Wong KH; Thompson SE; Schalla WO; Logan LC
Can J Microbiol; 1977 Sep; 23(9):1261-5. PubMed ID: 409469
[TBL] [Abstract][Full Text] [Related]
6. Morphological, biological and antigenic properties of Neisseria gonorrhoeae adapted to growth in guinea-pig subcutaneous chambers.
Penn CW; Sen D; Veale DR; Parsons NJ; Smith H
J Gen Microbiol; 1976 Nov; 97(1):35-43. PubMed ID: 62821
[TBL] [Abstract][Full Text] [Related]
7. Gonococcal variants selected by growth in vivo or in vitro have antigenically different LPS.
Demarco de Hormaeche R; Jessop H; Senior K
Microb Pathog; 1988 Apr; 4(4):289-97. PubMed ID: 3143896
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the LPS determine virulence of Neisseria gonorrhoeae in guinea-pig subcutaneous chambers.
Demarco de Hormaeche R; Macpherson A; Bowe F; Hormaeche CE
Microb Pathog; 1991 Sep; 11(3):159-70. PubMed ID: 1800889
[TBL] [Abstract][Full Text] [Related]
9. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.
Ram S; Mackinnon FG; Gulati S; McQuillen DP; Vogel U; Frosch M; Elkins C; Guttormsen HK; Wetzler LM; Oppermann M; Pangburn MK; Rice PA
Mol Immunol; 1999; 36(13-14):915-28. PubMed ID: 10698346
[TBL] [Abstract][Full Text] [Related]
10. The Leeuwenhoek Lecture, 1991. The influence of the host on microbes that cause disease.
Smith H
Proc Biol Sci; 1991 Nov; 246(1316):97-105. PubMed ID: 1685245
[TBL] [Abstract][Full Text] [Related]
11. [Gonococcal surface antigens and their significance for serotyping and vaccines].
Kohl PK; Meyer TF; Petzoldt D
Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
[TBL] [Abstract][Full Text] [Related]
12. Human experimentation with Neisseria gonorrhoeae: progress and goals.
Cohen MS; Cannon JG
J Infect Dis; 1999 Mar; 179 Suppl 2():S375-9. PubMed ID: 10081510
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
